Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
-
-
Suspected Outbreak of Trichinellosis in North Carolina Associated with Undercooked Bear Meat
On Oct. 10, 2024, the U.S. Centers for Disease Control and Prevention announced that a 2023 presumed outbreak…
-
Study Analyzed Potato-Pathogen ‘Arms Race’ After Irish Famine
On Aug. 5, 2024, North Carolina State University researchers revealed that an examination of the genetic material found…
-
Bivalent boosters provided better protection against severe COVID-19
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
-
Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
-
Study found that for the unvaccinated, reinfection by COVID-19 was likely
On Oct. 19, 2021, National Science Foundation funded scientists at the Yale School of Public Health and the…
-
AIM ImmunoTech announced first COVID-19-induced chronic fatigue ﾓLong Haulerﾔ patient dosed with Ampligen
On Jan. 5, 2021, AIM ImmunoTech announced that the active AMP-511 Expanded Access Program (EAP) had dosed its…
-
Bayer acquired Asklepios BioPharmaceutical for $40 billion
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a North Carolina-headquartered biopharmaceutical company specialized in…
-
Henry Schein named exclusive distributor of second point-of-care antibody rapid test
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
-
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
-
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
-
Biotechnology | CDC | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
CDC published ACIP recommendations for use of herpes zoster vaccines
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
-
Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer Institute
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
-
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
-
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
-
Nobel Prize in Chemistry for 2015 awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar
On Oct. 7, 2015, the Nobel Prize in Chemistry for 2015 was awarded to Tomas Lindahl, Francis Crick…
-
RTP announced plans for a $50 million redevelopment
On Oct. 1, 2015 the President and CEO of the Research Triangle Foundation (RTP), Bob Geolas, announced RTP’s…
-
The North Carolina Eshelman School of Pharmacy received $100 million donation from Fred Eshelman
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
-
David H Murdock announced endowment for DHMRI
On Sept. 30, 2014, David H. Murdock, owner and chair of Castle & Cooke, and builder and founder…
-
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
-
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
-
The Belly Button Biodiversity project was launched
On Jan. 3, 2011, the Belly Button Biodiversity project was launched to investigate the microbes inhabiting our navels…
-
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
-
Oliver Smithies was awarded the 2007 Nobel Prize in Physiology or Medicine
On Oct. 8, 2007, the Nobel Prize in Physiology or Medicine was awarded jointly to Oliver Smithies from…
-
David H Murdock donated $35 million to Duke University to fund the Measurement to Understand the Reclassification of Disease
On Sept. 24, 2007, David H. Murdock donated $35 million to Duke University to fund the Measurement to…
-
Groundbreaking was held for the North Carolina Research Campus
On Feb. 23, 2006, groundbreaking was held for the first building of the North Carolina Research Campus (NCRC),…
-
The CDC activated its Emergency Operations Center for Tropical Storm Ernesto
Aug. 24, 2024, the U.S. Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center (EOC)…
-
David H Murdock announced a $1.5 billion North Carolina Research Campus
On Sept. 12, 2005, David H. Murdock announced a $1.5 billion scientific and economic revitalization project called the…
-
David H Murdock purchased the former Cannon Mills site at auction, future home of the North Carolina Research Campus
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
-
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
